Tute Genomics Now Available in Illumina's BaseSpace Apps
PROVO, Utah, Nov. 4, 2014 /PRNewswire-iReach/ Tute Genomics announced today that it has added its genome annotation and interpretation platform to BaseSpace Apps, Illumina's dedicated applications store and informatics community dedicated to advancing genomic analysis.
Tute provides users with a simple and intuitive interface to aid in identification and prioritization of functionally significant genetic variants. Tute annotates single nucleotide variants (SNVs) and insertion/deletions (INDELs) for their effect on genes, incorporating more than 150 annotation sources including conservation scores, functional predictions, disease databases, and allele frequencies. Users of the platform can generate reports, apply variant filters, and perform family-based, case-control and tumor-normal analyses streamlining the interpretation of next-generation sequencing data.
"Illumina is the market leader in next-generation sequencing, and we are excited to leverage BaseSpace. We strongly believe that this offering will make genome analysis even more efficient and streamlined, with data flowing directly from sequencers and other applications into our genome interpretation platform," said Dr. Kai Wang, President of Tute Genomics.
"This integration with Illumina's BaseSpace is an important step to speed up genetic discoveries as we work towards genome-guided, individualized medicine," added Dr. Reid Robison, CEO of Tute Genomics.
When users upload a file from the Illumina sequencer, the sequence data goes into BaseSpace. Users can then choose from the list of available apps, including Tute, to complete their analysis. Genome variant files can be streamed directly from BaseSpace into the Tute app.
Informatics solutions available through BaseSpace Apps allow customers to utilize the tools from a growing community of academic, commercial, and open source providers.
About Tute Genoimcs
Tute Genomics is a Utah-based company developing innovative cloud-based solutions and powering the world's genomic knowledge, to accelerate genetic discovery and enable precision medicine. Tute has developed a genome annotation and interpretation platform that assists researchers in identifying disease genes and biomarkers from next-generation sequencing data. Tute is built on the expertise that developed ANNOVAR, the most widely used genome annotation & interpretation technology with over 900 scientific citations. To learn more please visit www.tutegenomics.com and follow us on twitter @TuteGenomics.
Media Contact: Reid Robison, Tute Genomics, (858) 779-4363, [email protected]
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Tute Genomics